{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:11:53Z","timestamp":1776301913960,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001858","name":"Sweden's Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008444","name":"Parkinson's Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007067","name":"Kemp Foundations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005701","name":"\u00c5hl\u00e9n Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004200","name":"Stiftelsen Olle Engkvist Byggm\u00e4stare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008584","name":"Stiftelsen L\u00e4ngmanska Kulturfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009389","name":"Promobilia foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009389","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010769","name":"Petrus and Augusta Hedlunds Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005753","name":"Royal Physiographic Society of Lund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.neurot.2024.e00334","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T15:56:12Z","timestamp":1708098972000},"page":"e00334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis"],"prefix":"10.1016","volume":"21","author":[{"given":"Tiberiu Loredan","family":"Stan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolaziz","family":"Ronaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian A.","family":"Barrientos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4r","family":"Halje","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Censoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Garro-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azat","family":"Nasretdinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgenya","family":"Malinina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Hjorth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peder","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Waters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristoffer","family":"Sahlholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Petersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","article-title":"The neuropsychiatry of Parkinson's disease: advances and challenges","volume":"21","author":"Weintraub","year":"2022","journal-title":"Lancet Neurol [Internet]"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00334_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11940-010-0072-y","article-title":"Parkinson's psychosis","volume":"12","author":"Zahodne","year":"2010","journal-title":"Curr Treat Options Neurol [Internet]"},{"issue":"1\u20132","key":"10.1016\/j.neurot.2024.e00334_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","article-title":"Epidemiology of psychosis in Parkinson's disease","volume":"289","author":"F\u00e9nelon","year":"2010","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.neurot.2024.e00334_bib4","series-title":"Hallucinations and delusions associated with Parkinson's disease psychosis: safety of current treatments and future directions [Internet]","first-page":"1","author":"Isaacson","year":"2022"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00334_bib5","first-page":"996","article-title":"A\u00a012-year population-based study of psychosis in Parkinson disease","volume":"67","author":"Forsaa","year":"2010","journal-title":"Arch Neurol [Internet]"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00334_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease\u2014an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov Disord [Internet]"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00334_bib7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/appi.ajp.2012.12030342","article-title":"Atypical antipsychotic use in patients with dementia: managing safety concerns","volume":"169","author":"Steinberg","year":"2012","journal-title":"Am J Psychiatr [Internet]"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00334_bib8","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/17512433.2017.1369405","article-title":"Pimavanserin, a novel antipsychotic for management of Parkinson's disease psychosis","volume":"10","author":"Kianirad","year":"2017","journal-title":"Expet Rev Clin Pharmacol [Internet]"},{"key":"10.1016\/j.neurot.2024.e00334_bib9","first-page":"100143","article-title":"Long-term outcomes with pimavanserin for psychosis in clinical practice","volume":"6","author":"Akbar","year":"2022","journal-title":"Clin Park Relat Disord [Internet]"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00334_bib10","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc Natl Acad Sci U S A [Internet]"},{"issue":"6833","key":"10.1016\/j.neurot.2024.e00334_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35075076","article-title":"BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization","volume":"411","author":"Guillin","year":"2001","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00334_bib12","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function","volume":"9","author":"B\u00e9zard","year":"2003","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00334_bib13","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/WNL.0000000000002285","article-title":"D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia","volume":"86","author":"Payer","year":"2016","journal-title":"Neurology [Internet]"},{"issue":"2\u20133","key":"10.1016\/j.neurot.2024.e00334_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0165-0173(99)00043-0","article-title":"Possible implications of the dopamine D3 receptor in schizophrenia and in antipsychotic drug actions","volume":"31","author":"Schwartz","year":"2000","journal-title":"Brain Res Rev [Internet]"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib15","article-title":"Safety and tolerability of IRL790 in Parkinson's disease with levodopa-induced dyskinesia-a phase 1b trial","volume":"4","author":"Svenningsson","year":"2018","journal-title":"NPJ Parkinsons Dis [Internet]"},{"key":"10.1016\/j.neurot.2024.e00334_bib16","series-title":"MDS international congress","article-title":"Results from IRL790C005 - a randomized, double-blind, placebo-controlled phase IIb study evaluating the efficacy of mesdopetam on daily on-time without troublesome dyskinesia in patients with parkinson\u2019s disease - MDS abstracts","author":"Antonini","year":"2023"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1124\/jpet.119.264226","article-title":"Preclinical pharmacology of [2-(3-fluoro-5-methanesulfonylphenoxy) ethyl](propyl)amine (IRL790), a novel dopamine transmission modulator for the treatment of motor and psychiatric complications in Parkinson disease","volume":"374","author":"Waters","year":"2020","journal-title":"J\u00a0Pharmacol Exp Therapeut [Internet]"},{"key":"10.1016\/j.neurot.2024.e00334_bib18","first-page":"393","article-title":"Design of a high-density multi-channel electrode for multi-structure parallel recordings in rodents","volume":"2014","author":"Ivica","year":"2014","journal-title":"Conf Proc IEEE Eng Med Biol Soc [Internet]"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00334_bib19","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1152\/jn.00868.2015","article-title":"Systems level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia","volume":"115","author":"Tamte","year":"2016","journal-title":"J\u00a0Neurophysiol [Internet]"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00334_bib20","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S0022-3565(24)39184-0","article-title":"Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A","volume":"294","author":"Reavill","year":"2000","journal-title":"J\u00a0Pharmacol Exp Therapeut [Internet]"},{"key":"10.1016\/j.neurot.2024.e00334_bib21","first-page":"382","article-title":"Verification of multi-structure targeting in chronic microelectrode brain recordings from CT scans","author":"Censoni","year":"2022","journal-title":"J\u00a0Neurosci Methods [Internet]"},{"key":"10.1016\/j.neurot.2024.e00334_bib22","first-page":"11","article-title":"Non-dopaminergic alterations in depression-like FSL rats in experimental parkinsonism and L-DOPA responses","author":"Schintu","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib23","article-title":"Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice","volume":"41","author":"Angela Cenci","year":"2007","journal-title":"Curr Protoc Neurosci [Internet]"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.bjp.0704451","article-title":"Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, \u03b11- and 5-HT2A-receptors","volume":"135","author":"Sebban","year":"2002","journal-title":"Br J Pharmacol [Internet]"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00334_bib25","doi-asserted-by":"crossref","first-page":"e784","DOI":"10.1038\/tp.2016.51","article-title":"Reversal of evoked gamma oscillation deficits is predictive of antipsychotic activity with a unique profile for clozapine","volume":"6","author":"Hudson","year":"2016","journal-title":"Transl Psychiatry [Internet]"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2007.04.021","article-title":"Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine","volume":"182","author":"Zhang","year":"2007","journal-title":"Behav Brain Res"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00334_bib27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/FBP.0b013e32834aff98","article-title":"Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease","volume":"22","author":"McFarland","year":"2011","journal-title":"Behav Pharmacol"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00334_bib28","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/s41596-019-0176-0","article-title":"Using DeepLabCut for 3D markerless pose estimation across species and behaviors","volume":"14","author":"Nath","year":"2019","journal-title":"Nat Protoc"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00334_bib29","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","article-title":"DeepLabCut: markerless pose estimation of user-defined body parts with deep learning","volume":"21","author":"Mathis","year":"2018","journal-title":"Nat Neurosci [Internet]"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10548-015-0448-0","article-title":"Separating fractal and oscillatory components in the power spectrum of neurophysiological signal","volume":"29","author":"Wen","year":"2016","journal-title":"Brain Topogr"},{"key":"10.1016\/j.neurot.2024.e00334_bib31","series-title":"Permutation entropy (fast algorithm)","author":"Unakafova","year":"2018"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00334_bib32","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.3390\/e15104392","article-title":"Efficiently measuring complexity on the basis of real-world data","volume":"15","author":"Unakafova","year":"2013","journal-title":"Entropy [Internet]"},{"key":"10.1016\/j.neurot.2024.e00334_bib33","unstructured":"Bechtold B, Fletcher P, Holden S, Gorur-Shandilya S. bastibe\/Violinplot-Matlab: A Good Starting Point."},{"key":"10.1016\/j.neurot.2024.e00334_bib34","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2007"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00334_bib35","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.0953-816x.2001.01743.x","article-title":"Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease","volume":"14","author":"Westin","year":"2001","journal-title":"Eur J Neurosci [Internet]"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00334_bib36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1460-9568.2003.02469.x","article-title":"Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment","volume":"17","author":"Andersson","year":"2003","journal-title":"Eur J Neurosci [Internet]"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00334_bib37","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.27337","article-title":"Animal models of l-dopa-induced dyskinesia in Parkinson's disease","volume":"33","author":"Cenci","year":"2018","journal-title":"Mov Disord [Internet]"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00334_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tics.2010.04.004","article-title":"Large-scale brain networks in cognition: emerging methods and principles","volume":"14","author":"Bressler","year":"2010","journal-title":"Trends Cognit Sci"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00334_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.npp.1380103","article-title":"Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated","volume":"11","author":"\u00d6gren","year":"1994","journal-title":"Neuropsychopharmacology [Internet]"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2011.03.031","article-title":"Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion","volume":"222","author":"Hsieh","year":"2011","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib41","doi-asserted-by":"crossref","DOI":"10.1007\/s13311-022-01309-5","article-title":"Distinctive effects of D1 and D2 receptor agonists on cortico-basal ganglia oscillations in a rodent model of L-DOPA-induced dyskinesia","volume":"20","author":"Skovg\u00e5rd","year":"2023","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1152\/jn.00590.2018","article-title":"Oscillations in cortico-basal ganglia circuits: implications for Parkinson's disease and other neurologic and psychiatric conditions","volume":"122","author":"Halje","year":"2019","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.neurot.2024.e00334_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.expneurol.2018.01.010","article-title":"Neurophysiological effects in cortico-basal ganglia-thalamic circuits of antidyskinetic treatment with 5-HT 1A receptor biased agonists","volume":"302","author":"Brys","year":"2018","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib44","first-page":"183","article-title":"Significance and translational value of high-frequency cortico-basal ganglia oscillations in Parkinson's disease","volume":"9","author":"Petersson","year":"2019","journal-title":"J\u00a0Parkinsons Dis"},{"key":"10.1016\/j.neurot.2024.e00334_bib45","series-title":"Progress in brain research","first-page":"525","article-title":"Basal ganglia oscillations as biomarkers for targeting circuit dysfunction in Parkinson's disease","author":"Petersson","year":"2020"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00334_bib46","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.biopsych.2006.01.020","article-title":"Ketamine dose-dependently induces high-frequency oscillations in the nucleus accumbens in freely moving rats","volume":"60","author":"Hunt","year":"2006","journal-title":"Biol Psychiatr"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00334_bib47","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1177\/0269881109102539","article-title":"Local injection of MK801 modifies oscillatory activity in the nucleus accumbens in awake rats","volume":"24","author":"Hunt","year":"2010","journal-title":"J\u00a0Psychopharmacol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00334_bib48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41386-018-0173-y","article-title":"The olfactory bulb is a source of high-frequency oscillations (130\u2013180 Hz) associated with a subanesthetic dose of ketamine in rodents","volume":"44","author":"Hunt","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00334_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021814","article-title":"Ketamine-induced oscillations in the motor circuit of the rat basal ganglia","volume":"6","author":"Nicol\u00e1s","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00334_bib50","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.euroneuro.2013.01.012","article-title":"NMDA receptor\u00a0antagonist-enhanced high frequency oscillations: are they generated broadly or regionally specific?","volume":"23","author":"Olszewski","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neurot.2024.e00334_bib51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pnpbp.2015.03.016","article-title":"Aberrant high frequency oscillations recorded in the rat nucleus accumbens in the methylazoxymethanol acetate neurodevelopmental model of schizophrenia","volume":"61","author":"Goda","year":"2015","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib52","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s42003-023-05093-6","article-title":"5-HT2AR and NMDAR psychedelics induce similar hyper-synchronous states in the rat cognitive-limbic cortex-basal ganglia system","volume":"6","author":"Brys","year":"2023","journal-title":"Commun Biol"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00334_bib53","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1017\/S1461145712001034","article-title":"Antipsychotic compounds differentially modulate high-frequency oscillations in the rat nucleus accumbens: a comparison of first- and second-generation drugs","volume":"16","author":"Olszewski","year":"2013","journal-title":"Int J Neuropsychopharmacol\/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"issue":"Nov 19","key":"10.1016\/j.neurot.2024.e00334_bib54","first-page":"1","article-title":"Spinal cord stimulation alleviates motor symptoms in a primate model of Parkinson's disease","volume":"84","author":"Santana","year":"2014","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00334_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-32649-7","article-title":"A\u00a0whole-brain model of the neural entropy increase elicited by psychedelic drugs","volume":"13","author":"Herzog","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00334_bib56","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/bja\/aen290","article-title":"Permutation entropy of the electroencephalogram: a measure of anaesthetic drug effect","volume":"101","author":"Olofsen","year":"2008","journal-title":"Br J Anaesth"},{"issue":"PART 1","key":"10.1016\/j.neurot.2024.e00334_bib57","first-page":"280","article-title":"Permutation entropy for discriminating \u201cconscious\u201d and \u201cunconscious\u201d state in general anesthesia","volume":"363 AICT","author":"Nicolaou","year":"2011","journal-title":"IFIP Adv Inf Commun Technol"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00334_bib58","article-title":"Dopamine D3 receptor plasticity in Parkinson's disease and L-DOPA-induced dyskinesia","volume":"9","author":"Lanza","year":"2021","journal-title":"Biomedicines [Internet]"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00334_bib59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S1092852916000602","article-title":"Parkinson's disease psychosis as a serotonin-dopamine imbalance syndrome","volume":"21","author":"Stahl","year":"2016","journal-title":"CNS Spectr [Internet]"},{"key":"10.1016\/j.neurot.2024.e00334_bib60","first-page":"12","article-title":"Bridging the gap? Altered thalamocortical connectivity in psychotic and psychedelic states","author":"Avram","year":"2021","journal-title":"Front Psychiatr"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00334_bib61","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1111\/ejn.15800","article-title":"Brain entropy, fractal dimensions and predictability: a review of complexity measures for EEG in healthy and neuropsychiatric populations","volume":"56","author":"Lau","year":"2022","journal-title":"Eur J Neurosci [Internet]"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:14:11Z","timestamp":1761808451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924000205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1878747924000205"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00334","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurophysiological treatment effects of mesdopetam, pimavanserin and clozapine in a rodent model of Parkinson's disease psychosis","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00334"}}